"Bilirubin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A bile pigment that is a degradation product of HEME.
| Descriptor ID |
D001663
|
| MeSH Number(s) |
D03.383.129.578.840.249.184 D03.633.400.909.249.184 D04.345.783.249.184 D23.767.193.184
|
| Concept/Terms |
Bilirubin, Calcium Salt- Bilirubin, Calcium Salt
- Calcium Salt Bilirubin
- Salt Bilirubin, Calcium
- Calcium Bilirubinate
- Bilirubinate, Calcium
|
Below are MeSH descriptors whose meaning is more general than "Bilirubin".
Below are MeSH descriptors whose meaning is more specific than "Bilirubin".
This graph shows the total number of publications written about "Bilirubin" by people in this website by year, and whether "Bilirubin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bilirubin" by people in Profiles.
-
The effects of blood and blood products on the arachnoid cell. Exp Brain Res. 2017 06; 235(6):1749-1758.
-
Ceftriaxone-Associated Biliary and Cardiopulmonary Adverse Events in Neonates: A Systematic Review of the Literature. Paediatr Drugs. 2017 Feb; 19(1):21-34.
-
Lysozyme and bilirubin bind to ACE and regulate its conformation and shedding. Sci Rep. 2016 10 13; 6:34913.
-
Importance of primary indication and liver function between stages: results of a multicenter Italian audit of ALPPS 2012-2014. HPB (Oxford). 2016 05; 18(5):419-27.
-
Prognostic criteria for postoperative mortality in 170 patients undergoing major right hepatectomy. Hepatobiliary Pancreat Dis Int. 2012 Oct; 11(5):507-12.
-
Hyperlipidemia due to biliary stricture after living-donor liver transplantation. Transplantation. 2011 Sep 27; 92(6):e29-30.
-
An evaluation of hepatotoxicity and nephrotoxicity of liposomal amphotericin B (L-AMB). J Med Toxicol. 2011 Mar; 7(1):12-5.
-
Donor-specific HLA-antibody-mediated humoral rejection in a liver transplant recipient fully reversed with plasmapheresis and immunoglobulin. Clin Transpl. 2006; 479-82.
-
Single-center experience: tacrolimus and mycophenolate mofetil in early stage of kidney transplantation with liver dysfunction. Transplant Proc. 2003 Feb; 35(1):273-4.
-
Reactivation of hepatitis B in patients with human immunodeficiency virus infection treated with combination antiretroviral therapy. Am J Med. 2000 Feb 15; 108(3):249-51.